UBE2F, a neddylation E2, neddylates CUL5 to activate cullin-RING ligase-5, upon coupling with neddylation E3 RBX2/SAG. Whether and how UBE2F controls pancreatic tumorigenesis is previously unknown. Here, we showed that UBE2F is essential for the growth of human pancreatic cancer cells with KRAS mutation. In the mouse KrasG12D pancreatic ductal adenocarcinoma (PDAC) model, Ube2f deletion suppresses cerulein-induced pancreatitis, and progression of acinar-to-ductal metaplasia (ADM) and pancreatic intraepithelial neoplasia. Mechanistically, Ube2f deletion inactivates the Mapk-c-Myc signals via blocking ubiquitylation of Diras2, a substrate of CRL5Asb11 E3 ligase. Biologically, DIRAS2 suppresses growth and survival of human pancreatic cancer cells harboring mutant KRAS, and Diras2 deletion largely rescues the phenotypes induced by Ube2f deletion. Collectively, Ube2f or Diras2 plays a tumor-promoting or tumor-suppressive role in the mouse KrasG12D PDAC model, respectively. The UBE2F-CRL5ASB11 axis could serve as a valid target for pancreatic cancer, whereas the levels of UBE2F or DIRAS2 may serve as prognostic biomarkers for PDAC patients.
Pubmed ID: 38574733 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets FLAG
View all literature mentionsThis monoclonal targets Ly-6G
View all literature mentionsThis monoclonal targets F4/80
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets UBE2M
View all literature mentionsThis polyclonal targets UBE2F
View all literature mentionsThis monoclonal targets Sox9
View all literature mentionsThis monoclonal targets Rbx1
View all literature mentionsThis monoclonal targets Hras1
View all literature mentionsThis monoclonal targets Phospho-Akt (Ser473)
View all literature mentionsThis unknown targets Rabbit Normal igg Control antibody
View all literature mentionsThis monoclonal targets Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204)
View all literature mentionsThis monoclonal targets p44/42 MAPK (Erk1/2)
View all literature mentionsThis monoclonal targets MUC5AC
View all literature mentionsThis recombinant monoclonal targets Ki67
View all literature mentionsThis polyclonal targets FLAG
View all literature mentionsThis polyclonal secondary targets not applicable
View all literature mentionsThis monoclonal targets FLAG
View all literature mentionsThis polyclonal targets DIRAS2
View all literature mentionsThis polyclonal targets Cullin 5/CUL-5
View all literature mentionsThis monoclonal targets IQGAP1 (C-9)
View all literature mentionsThis monoclonal targets c-Myc (D84C12) XP Rabbit mAb
View all literature mentionsThis monoclonal targets BRAF
View all literature mentionsThis polyclonal targets Human ASB11
View all literature mentionsThis unknown targets HA
View all literature mentionsThis polyclonal targets Beta Actin
View all literature mentionsThis monoclonal targets APOBEC3B
View all literature mentionsMus musculus with name C57BL/6JGpt-Diras2em1Cflox/Gpt from IMSR.
View all literature mentionsCell line PANC-1 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsMus musculus with name B6.129S4-Krastm4Tyj/J from IMSR.
View all literature mentionsMus musculus with name STOCK Ptf1atm1(cre)Hnak/RschJ from IMSR.
View all literature mentionsCell line MIA PaCa-2 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line HEK293 is a Transformed cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line BxPC-3 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentions